Gyre Therapeutics, Inc. GYRE Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | $11.82M+35.3% | $8.74M-25.3% | $11.7M-34.6% | ||
| $2.62M+5.5% | $2.48M+8.5% | $2.29M+9.8% | $2.08M+24.7% | $1.67M+7.7% | ||
| $9.23M+29.0% | $7.16M+129% | $3.13M+41.0% | $2.22M+67.1% | $1.33M+59.7% | ||
| —— | —— | $3.88M— | —— | —— | ||
| $1.25M+4.7% | $1.19M+13.8% | $1.05M-2.3% | $1.07M-52.8% | $2.27M-4.6% | ||
| —— | —— | -$4.33M+20.9% | -$5.47M+48.9% | -$10.7M+46.2% | ||
| $23.06M-5.4% | $24.38M-2.6% | $25.02M+0.2% | $24.98M+796% | $2.79M+32.6% | ||
| —— | —— | $24.54M+20.3% | $20.39M+238% | -$14.74M+32.1% | ||
| $3.07M+1,807% | -$180K-106% | $2.9M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Gyre Therapeutics, Inc. generate?
- Gyre Therapeutics, Inc. (GYRE) generated $9.8M in operating cash flow over the trailing twelve months.
- What is Gyre Therapeutics, Inc.'s free cash flow?
- After $1.2M of capital expenditures, Gyre Therapeutics, Inc.'s free cash flow was $3.1M over the trailing twelve months, up 142.4% year over year.
- Where does Gyre Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Gyre Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
